Nasal-type Natural Killer T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Nasal-type Natural Killer T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating anlotinib in advanced and refractory natural killer / T-cell lymphoma has completed.